Trident Lifeline (TLL) Share Price Rises 8.20% to Rs 409
- September 4, 2026
- Posted by: Kunal Singla
- Category: News
Trident Lifeline Share Price is rising today after the stock moved to Rs 409 from a previous close of Rs 378, up Rs 31 or 8.20%. The company’s market capitalisation stood at Rs 456.16 Cr, placing Trident Lifeline Share Price news in focus for readers tracking Healthcare names on the Indian stock market. The price move is confirmed in Univest data; a company-specific reason has not been established. That makes the move primarily a price action story for now, with the numbers themselves doing the talking. The stock opened at Rs 384, touched a high of Rs 409 and a low of Rs 384, so Trident Lifeline Share Price spent the day inside a tight opening band before reaching the current level. Investors following Univest can use this move as a starting point to study valuation, peer context and sector positioning rather than treat the rise as a standalone signal.
Trident Lifeline Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 409 |
| Previous Close | Rs 378 |
| Today's Move | Rs 31 (+8.2%) |
| Open | Rs 384 |
| High | Rs 409 |
| Low | Rs 384 |
| Market Capitalisation | Rs 456.16 crore |
| Market Cap Category | Micro Cap |
Trident Lifeline Ltd. (TLL) rose to Rs 409 from the previous close of Rs 378, a move of Rs 31 or 8.2%. The stock opened at Rs 384, reached a high of Rs 409, recorded a low of Rs 384.
Trident Lifeline Share Price today shows a clean intraday rise from Rs 378 to Rs 409, with the stock up Rs 31, or 8.20%. It opened at Rs 384, stayed within the Rs 384 to Rs 409 range and last traded at Rs 409. That places Trident Lifeline Share Price at the top of the day’s band, while the market capitalisation of Rs 456.16 Cr shows the company’s current scale in the market.
For readers tracking Trident Lifeline Share Price today, the key point is simple: the move is verified, the level is specific and the day’s range is known. Univest data confirms the rise, but no company-specific catalyst is established. In such a case, price action analysis matters more than assumptions. Trident Lifeline Share Price also stands out because the gain came without any need to infer a reason from the figures. The next step is to place Trident Lifeline Share Price in a fundamental analysis framework.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 456.16 crore |
| P/E Ratio | 23.74x |
| P/B Ratio | 4.59x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.92 |
| Book Value Per Share | Rs 82.4 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 23.74x, P/B 4.59x, ROE 18.78%, ROCE 19.17%. These ratios show where the company stands today and are not a call to buy or sell.
Trident Lifeline Ltd. has a market capitalisation of Rs 456.16 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.74x, P/B at 4.59x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.72x, median ROE of 11.61%, median ROCE of 13.46%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 23.74x |
| Benchmark Median P/E | 31.72x |
| Benchmark Average P/E | 46.74x |
| Benchmark P/E Range | 3.11x to 663.29x |
| Company P/B Ratio | 4.59x |
| Benchmark Median P/B | 2.91x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.61% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 456.16 crore |
| Benchmark Median Market Cap | Rs 821.94 crore |
Trident Lifeline Ltd. (TLL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 23.74x, which is below the benchmark median of 31.72x, a difference of -25.16%. A P/E difference of this kind is a reference point rather than a recommendation.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.61%, a difference of +61.76%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.46%, a difference of +42.42%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,22,067.01 | 35.09 | 4.91 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,982.98 | 84.18 | 13.94 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,77,974.12 | 80.83 | 19.64 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,13,615.69 | 25 | 4.18 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 1,11,898.66 | 101.36 | 19.65 | 18.31 | 18.2 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 23.74x compared with the displayed peer median of 80.83x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 456.16 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Trident Lifeline
- Trident Lifeline Share Price rose 8.20% to Rs 409, with the day’s move clearly verified by the latest Univest figures.
- Trident Lifeline Share Price is backed by ROE of 18.78% and ROCE of 19.17%, which are useful context points in Healthcare.
- Trident Lifeline Share Price carries a P/E of 23.74 and P/B of 4.59, so valuation remains central to any stock analysis.
- Trident Lifeline Share Price is trading with a market capitalisation of Rs 456.16 Cr, which frames the company’s scale within its industry.
- Trident Lifeline Share Price has no confirmed company-specific catalyst in the visible data, so investors may track fresh Trident Lifeline Stock News and Healthcare sector updates on Univest.
About Trident Lifeline
Trident Lifeline Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following Trident Lifeline Share Price, the company belongs to a part of the market that is usually assessed through profitability, valuation and relative positioning rather than only through intraday moves. The current set of numbers shows market cap, earnings ratios and return ratios, so Trident Lifeline Share Price can be viewed in the same analytical frame as other listed pharmaceutical businesses on Univest.
The company’s share price context today is therefore tied to both trading levels and basic financial strength. EPS of 15.92, book value of Rs 82.4, ROE of 18.78% and ROCE of 19.17% give Trident Lifeline Share Price a measurable financial backdrop. Investors using Trident Lifeline Share Price news, Trident Lifeline Stock News and Trident Lifeline Stock Analysis can compare the company with peers in the same industry and judge how it sits inside the broader Healthcare market update.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Trident Lifeline Share Price rise today?
Ans. Trident Lifeline Share Price rose 8.20% to Rs 409 from Rs 378. According to Univest data, the price event is confirmed, but no company-specific catalyst is established, so the move should be read as price action first.
What is Trident Lifeline Share Price today?
Ans. Trident Lifeline Share Price is Rs 409 in the latest Univest figures. It moved up Rs 31 from the previous close of Rs 378, and the market capitalisation stood at Rs 456.16 Cr.
What is Trident Lifeline Share Price today’s percentage gain?
Ans. Trident Lifeline Share Price is up 8.20% today. The stock opened at Rs 384, touched Rs 409 and remained within that range during the move shown by Univest data.
What does Trident Lifeline fundamental analysis show?
Ans. Trident Lifeline Share Price is supported by P/E of 23.74, P/B of 4.59, ROE of 18.78%, ROCE of 19.17%, EPS of 15.92 and book value of Rs 82.4. Dividend yield is 0.
How is Trident Lifeline valued versus its industry?
Ans. Trident Lifeline Share Price trades below the industry P/E median of 31.72 and average of 46.74, while its P/B of 4.59 is above the benchmark median of 2.91 and average of 4.27.
How does Trident Lifeline compare with peers?
Ans. Trident Lifeline Share Price has a smaller market cap than peers such as Sun Pharmaceutical Industries Ltd., Divi's Laboratories Ltd. and Torrent Pharmaceuticals Ltd. Its P/E is also lower than several peer valuations in the same industry.
Which sector and industry does Trident Lifeline belong to?
Ans. Trident Lifeline Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That places the stock within a benchmark set of 199 companies in the same industry.
Is Trident Lifeline giving dividend income?
Ans. Trident Lifeline Share Price has a dividend yield of 0% in the current figures. Investors looking at the stock therefore need to focus more on valuation, earnings and return ratios than on income.
Track Trident Lifeline Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Trident Lifeline Share Price can be tracked on Univest for live price movement, key valuation ratios, 52-week levels and market insights in one place. Readers can review Trident Lifeline Share Price today alongside Trident Lifeline Stock News, Trident Lifeline Share Price Live updates and financial context whenever the stock is moving. Univest also helps users compare the company’s market cap, P/E ratio, P/B ratio, ROE and ROCE with its peers and sector benchmark.
For anyone watching Trident Lifeline Share Price Update or Trident Lifeline Latest News, the platform makes it easier to follow price action and fundamental analysis together. That is especially useful when the stock rises without a stated catalyst, because the verified numbers and the company context become the main reference points.